Ionis Pharmaceuticals, Inc. (IONS) Stock Price Today & Analysis

IONS
IONS company logo
Loading...
Chart by TradingViewData delayed 15 minutes

Valuation

Market cap$13.06B
Price-to-sales ratio13.50
Price-to-book value21.13
Price-earnings ratio-50.90
Return on Equity-44.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A

Earnings Per Share

Earnings Per Share$-1.61

Income Statement

Average volume2,289,013
EBITDA$-147.39M
1 year high (52w)$86.74
1 year low (52w)$23.95

Dividend

Dividend yield0.00%

Solvency

Debt-to-equity ratioN/A

About Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis received FDA approval in 2024 for Tryngolza for a rare high-triglyceride syndrome, marking its first independent launch.

FAQ

Buying Ionis Pharmaceuticals, Inc. (IONS) stock is now easy and instant through the Gotrade app.
  1. Download the Gotrade app from the App Store or Google Play.
  2. Create an account and complete KYC.
  3. Make a deposit.
  4. Search for the code "IONS", then tap "Trade".
  5. Tap the "Buy" button.
  6. Enter the amount you want to buy. You have two options:
    1. Buy IONS by number of shares.
    2. Buy fractional shares in dollars, starting from $1.
  7. Swipe up to confirm your order—done!
On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Ionis Pharmaceuticals, Inc. from just $1. A small budget shouldn't stop you from building a US stock portfolio.
At the moment, Ionis Pharmaceuticals, Inc. (IONS) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track IONS's performance via the price chart in the Gotrade app.
Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).
You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.
Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.
There's no single perfect answer, but common approaches include:
  • Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
  • Review revenue and earnings growth.
  • Check margins and cash flow.
  • Evaluate business outlook and the company's position within its industry.
You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Related news

AppLogo

Buy saham IONS
di Gotrade

AppLogo

Gotrade